| http://www.w3.org/ns/prov#value | - Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual f...ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients...es Litigation Reform Act of 1995, including statements relating to potential market for ASMANEX. Forward-looking statements relate to expectations
|
